Lianhe Chemical Technology Co.,Ltd.

SZSE:002250 Stock Report

Market Cap: CN¥5.4b

Lianhe Chemical TechnologyLtd Past Earnings Performance

Past criteria checks 0/6

Lianhe Chemical TechnologyLtd's earnings have been declining at an average annual rate of -21%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 9.4% per year.

Key information

-21.0%

Earnings growth rate

-22.6%

EPS growth rate

Chemicals Industry Growth12.1%
Revenue growth rate9.4%
Return on equity-4.5%
Net Margin-6.2%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Little Excitement Around Lianhe Chemical Technology Co.,Ltd.'s (SZSE:002250) Revenues

Oct 24
Little Excitement Around Lianhe Chemical Technology Co.,Ltd.'s (SZSE:002250) Revenues

Is Lianhe Chemical TechnologyLtd (SZSE:002250) Using Debt In A Risky Way?

Sep 25
Is Lianhe Chemical TechnologyLtd (SZSE:002250) Using Debt In A Risky Way?

Lianhe Chemical TechnologyLtd's (SZSE:002250) Dividend Will Be Reduced To CN¥0.02

Jul 12
Lianhe Chemical TechnologyLtd's (SZSE:002250) Dividend Will Be Reduced To CN¥0.02

Why Investors Shouldn't Be Surprised By Lianhe Chemical Technology Co.,Ltd.'s (SZSE:002250) Low P/S

Jun 07
Why Investors Shouldn't Be Surprised By Lianhe Chemical Technology Co.,Ltd.'s (SZSE:002250) Low P/S

Returns Are Gaining Momentum At Lianhe Chemical TechnologyLtd (SZSE:002250)

Feb 28
Returns Are Gaining Momentum At Lianhe Chemical TechnologyLtd (SZSE:002250)

Revenue & Expenses Breakdown

How Lianhe Chemical TechnologyLtd makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSE:002250 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 245,783-357783261
30 Jun 245,755-476777290
31 Mar 245,950-507785340
31 Dec 236,442-465772372
30 Sep 236,982279709440
30 Jun 237,828517758442
31 Mar 238,130667732419
31 Dec 227,865697793388
30 Sep 227,749380775356
30 Jun 227,276331747340
31 Mar 226,851306774319
31 Dec 216,587315774310
30 Sep 216,097166754301
30 Jun 215,676191778269
31 Mar 215,528231813276
31 Dec 204,782110809256
30 Sep 204,40773900256
30 Jun 204,01614923239
31 Mar 203,703-45915216
31 Dec 194,284144832211
30 Sep 194,809349766188
30 Jun 194,681270664199
31 Mar 194,385129677176
31 Dec 184,11438650171
30 Sep 183,80816578145
30 Jun 183,99042569208
31 Mar 184,260183586175
31 Dec 174,107205624140
30 Sep 173,717195733117
30 Jun 173,2641867600
31 Mar 173,0212407160
31 Dec 163,0992646950
30 Sep 163,3194456950
30 Jun 163,8585827150
31 Mar 164,0295937250
31 Dec 154,0086387330
30 Sep 154,0656167090
30 Jun 154,1336127040
31 Mar 154,0405826700
31 Dec 143,9905516390
30 Sep 143,8525226390
30 Jun 143,6944975940
31 Mar 143,6164755550
31 Dec 133,3684505450

Quality Earnings: 002250 is currently unprofitable.

Growing Profit Margin: 002250 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 002250 is unprofitable, and losses have increased over the past 5 years at a rate of 21% per year.

Accelerating Growth: Unable to compare 002250's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 002250 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-5.3%).


Return on Equity

High ROE: 002250 has a negative Return on Equity (-4.46%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies